1) Stroke is a medical emergency that requires rapid diagnosis and treatment. Signs of stroke include sudden numbness or weakness in the face, arm or leg, especially on one side of the body. 2) If someone is experiencing signs of stroke, it is important to call emergency services immediately so they can be evaluated by a doctor as soon as possible. 3) Prompt medical care including clot-busting drugs may help reduce long-term disability for some stroke patients. Getting to the hospital quickly is critical for receiving optimal treatment.

1. Project: Ghana Emergency Medicine Collaborative
Document Title: Stroke Management in the 21st Century: What Do You
Need to Know?
Author(s): Rashmi Kothari (Michigan State University), MD 2012
License: Unless otherwise noted, this material is made available under the
terms of the Creative Commons Attribution Share Alike-3.0 License:
http://creativecommons.org/licenses/by-sa/3.0/
We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability
to use, share, and adapt it. These lectures have been modified in the process of making a publicly shareable
version. The citation key on the following slide provides information about how you may share and adapt this
material.
Copyright holders of content included in this material should contact open.michigan@umich.edu with any
questions, corrections, or clarification regarding the use of content.
For more information about how to cite these materials visit http://open.umich.edu/privacy-and-terms-use.
Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a
replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to
your physician if you have questions about your medical condition.
Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.
1

2. Attribution Key
for more information see: http://open.umich.edu/wiki/AttributionPolicy
Use + Share + Adapt
{ Content the copyright holder, author, or law permits you to use, share and adapt. }
Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105)
Public Domain – Expired: Works that are no longer protected due to an expired copyright term.
Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain.
Creative Commons – Zero Waiver
Creative Commons – Attribution License
Creative Commons – Attribution Share Alike License
Creative Commons – Attribution Noncommercial License
Creative Commons – Attribution Noncommercial Share Alike License
GNU – Free Documentation License
Make Your Own Assessment
{ Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. }
Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your
jurisdiction may differ
{ Content Open.Michigan has used under a Fair Use determination. }
Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your
jurisdiction may differ
Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your
use of the content is Fair.
2
To use this content you should do your own independent analysis to determine whether or not your use will be Fair.

3. !"#$%&$'($)*+($*,&-.$/.+&0(1$
• 2"3+%$4(*%356$)*-/($&7$%(*."$
• 8(*%356$)*-/($&7$*%-4.$%3/*,343.#$
• 9:;<:=$>&+.*43.#$
3

4. ?3%%4($@(+(,+*4$A57*+)B&5$
Source unknown
Source unknown
4

5. 23//-(;C4*/>35&6(5$D)BE*.&+$35$
D)-.($A/)"(>3)$F.+&0($
•
•
•
•
•
G&-,4(;,435%(%$
C4*)(,&$)&5.+&44(%$
:HI>6J06$
K9L$M*B(5./$
2+(*.(%$'3."35$<$"&-+/$
– NJ9$'3."35$I:$>35-.(/$
– NJ9$'3."35$IN;NO:$>35-.(/$
• L$P-.)&>($>(*/-+(/$
Reference: Tissue Plasminogen Activator for Acute Ischemic Stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group5
N Engl J Med 1995; 333:1581-1588. http://www.nejm.org/doi/full/10.1056/NEJM199512143332401.

6. QAQGF$+.;CD$F.+&0($2+3*4$R(/-4./$
• <:=$>&+($430(4#$.&$"*E($7*E&+*,4($<;>&5."$&-.)&>($
– !"#$SNH9;9HITUP%%/$R*B&$S:;I:$>35-.(/T$ $$
– !"$$SNH<;9HITUP%%/$R*B&$SIN;NO:T$$>35-.(/T$ $$
• F3653V)*5.4#$"36"(+$35.+*)(+(,+*4$"(>&++"*6($+*.($
– %"&=$C4*)(,&$
– &"'=$+.;CD$
• Q&$%3W(+(5)($35$>&+.*43.#$
– (!=$C4*)(,&$
– !$=$+.;CD$
6

7. 23>($.&$2+(*.>(5.$
• )*+,-*U$$$$."(+*M(-B)$ $
$$$$$$$$$$'35%&'$
• ."$*+,-*U$>(%3*5$B>($.&$
$$$$$$$$$$XG$*++3E*4$
• )"&/*U$$$$=$.+(*.(%$35$ $
$$$$$$$$$$QAQGF$SK9L$&7$ $$$$$$$$$$
NYZ<9LT$
Retro00064. Wikimedia Commons
7

8. Jmkim dot com, Wikimedia Commons
8

9. F.+&0($@"*35$&7$F-+E3E*4$[$R()&E(+#$
•
•
•
•
•
•
•
G(.()B&5$X*+4#$R()&653B&5$
G3/M*.)"$X*+4#$X?F$D)BE*B&5$
G(43E(+#$2+*5/M&+.$[$?*5*6(>(5.$
G&&+$XG$2+3*6($
G*.*$XG$XE*4-*B&5$[$?*5*6(>(5.$
G()3/3&5$FM()3V)$2"(+*M3(/$
G+-6$2"+&>,&4#B)$[$Q(-+&M+&.()BE($2"(+*M#$
9

10. G(.()B&5$
• !"*.$*+($F365/$[$F#>M.&>/1$
– L<=$6(5(+*4$M-,43)$%3%5 .$05&'$*5#$
– <I=$&7$*)-.($/.+&0($M*B(5./$%3%5 .$05&'$*5#$
• !"*.$*+($R3/0$]*).&+/1$
– <9=$6(5(+*4$M-,43)$%3%5 .$05&'$*5#$
– L<=$&7$*)-.($/.+&0($M*B(5./$%3%5 .$05&'$*5#$
Pancioli JAMA 1998;279
Kothari Stroke 1997;28
10

11. !"*.$%&$#&-$5((%$.&$05&'$*,&-.$/.+&0(1$
• F365/$[$F#>M.&>/$
– &5(;/3%(%$(^.+(>3.#$
'(*05(//$
– &5(;/3%(%$5->,5(//$
– %3_)-4.#$/M(*0356$
– E3/-*4$M+&,4(>/$
• R3/0$]*).&+/$
– "#M(+.(5/3&5$
– %3*,(.(/$>(443.-/$
– />&0356$
– "(*+.$%3/(*/($
– M+3&+$/.+&0(/$
– &4%(+$*6($
– +*)($SD7+3)*5;D>(+3)*5/T$
11

12. @35)355*B$C+("&/M3.*4$F.+&0($F)*4($
Shantoo, Wikimedia Commons
Facial Droop
Normal:
Abnormal:
Gonad, Wikimedia Commons
Normal:
Abnormal:
St Bartholomew's Hospital Archives &
Museum, Wellcome Images
Normal:
Abnormal:
Both sides of face move equally
One side of face does not move at all
Arm Drift
Both arms move equally or not at all
One arm drifts compared to the other
Speech
Patients use correct words with no slurring
Slurred or inappropriate words or mute
12

13. G3/M*.)"$@*44$INN$
Mark Wolfe, Wikimedia Commons
13

14. `(5(+*4$C-,43)/ $C(+)(MB&5$&7$!"*.$.&$%&$35$
@*/($&7$*$F.+&0($
• I:=$'&-4%$/((0$>(%3)*4$*a(5B&5$
– L<=$)*44$INN$3>>(%3*.(4#$
– 9K=$)*44$."(3+$7*>34#$%&).&+$
– NN=$6&$/.+*36".$.&$."($XG$
NSA/Gallop Poll 1996
14

15. Onset to ED Arrival (hours)
A53B*4$?(%3)*4$@&5.*).$E(+/-/$23>($&7$XG$
D++3E*4$
7
6
5
4
3
2
1
0
Barsan Arch Intern Med. 1993
6.3
5.6
4.5
3.5
2.6
Mean
Median
1.4
911
Private MD
ED
15

16. G(43E(+#$2+*5/M&+.$[$?*5*6(>(5.$
•
•
•
•
•
•
•
EyOne, Wikimedia Commons
Db@/$
F.+&0($+()&653B&5$
23>($&7$&5/(.$
Q(-+&4&63)*4$(E*4-*B&5$
@"()0$64-)&/($
X*+4#$"&/M3.*4$5&BV)*B&5$
R*M3%$2+*5/M&+.cccccc$
16

17. X>(+6(5)#$G(M*+.>(5.$?*5*6(>(5.$
•
•
•
•
G&&+$XG$2+3*6($
G*.*$XG$XE*4-*B&5$$
G()3/3&5$FM()3V)$2"(+*M3(/$
G+-6$2"+&>,&4#B)$2"(+*M#$
17
Russell Lee, Wikimedia Commons

18. Shantoo, Wikimedia Commons
2+3*6($
18

19. G*.*$
Photographer's Mate 1st Class Michael R. McCormick, Wikimedia Commons
19

20. G()3/3&5$
S!"&$F"&-4%$A$2+(*.1T$
• A5)4-/3&5$@+3.(+3*$
• X^)4-/3&5$@+3.(+3*$
20

21. $A5)4-/3&5$@+3.(+3*$
• @4353)*4$C+(/(5.*B&5$&7$A/)"(>3)$F.+&0($
• P5/(.$'3."35$<$"&-+/$
21

22. X^)4-/3&5$@+3.(+3*$
•
•
•
•
•
•
•
•
01-23*4)*+56,-*
784!9.:!!%*
d(>&++"*6($&5$@2$
;2<=6,2*>3*51-23$
F-+6(+#$NL$%*#/$
2+*->*$<$>&5."/$
F.+&0($$<$>&5."/$
?353>*4$&+$+(/&4E356$
/#>M.&>/$
•
•
•
•
•
•
•
`AJ`e$,4((%$9N$%*#/$
C+3&+$A@d$&+$FDd$
?2@213*AB*
P5$@&->*%35$C2fNHg$
01*+2C>,<1*8DD4(!$
C4*.(4(./$hN::Z:::$
EF6@5-2*4'%%$
22

23. G+-6$
Sd&'$G&$i&-$2+(*.1T$
• C+(;2+(*.>(5.$
– 64-)&/(Z$QAdFFZ$@2Z$@&5/(5.$
• G&/356$
• ?&53.&+356$
23

24. G&/356$
• :HI$>6J06$S>*^HUI:$>6T$
• N:=$,&4-/$S&E(+$N$
>35-.(T$
• N$"&-+$357-/3&5$
Mass Communication Specialist Seaman Andrew Skipworth, Wikimedia Commons
24

25. C*B(5.$?&53.&+356$
• A@e$*%>3//3&5$S9L$"&-+/T$
• Q(-+&$)"()0/$$
– j$Ng$>35-.($k$K$"&-+/$
– j$N$"&-+$k$NO$"&-+/$
• bC$)"()0/$$
25

26. b4&&%$C+(//-+($?*5*6(>(5.$
• Q&5;2"+&>,&4#B)$@*5%3%*.(/$
• 2"+&>,&4#B)$@*5%3%*.(/$
– M+(;.+(*.>(5.$SNOgJNN:$>>d6T$
– %-+356$[$M&/.;.+(*.>(5.$
26

27. bC$?*5*6(>(5.$
• Q&5;2"+&>,&4#B)$@*5%3%*.($
– G&5 .$2+(*.ccc$
• C+(;2"+&>,&4#/3/$
– b($`(5.4(ccc$
• G-+356$[$C&/.;2"+&>,&4#/3/$
– b($D66+(//3E(ccc$
27

28. QAQGF;R()&>>(5%(%$2*+6(./$
•
•
•
•
G&&+;.&;%&).&+ $ $ $N:$>35-.(/$
G&&+;.&;@2$ $ $ $$$$$$9g$>35-.(/$
G&&+;.&;@2$+(*%356 $$$$$$Lg$>35-.(/$
G&&+;.&;.+(*.>(5. $ $K:$>35-.(/$
28

29. F.+&0($@"*35$&7$F-+E3E*4$[$R()&E(+#$
•
•
•
•
•
•
•
G(.()B&5$X*+4#$R()&653B&5$
G3/M*.)"$X*+4#$X?F$D)BE*B&5$
G(43E(+#$2+*5/M&+.$[$?*5*6(>(5.$
G&&+$XG$2+3*6($
G*.*$XG$XE*4-*B&5$[$?*5*6(>(5.$
G()3/3&5$FM()3V)$2"(+*M3(/$
G+-6$2"+&>,&4#B)$[$Q(-+&M+&.()BE($2"(+*M#$
29

30. <;?&5."$]*E&+*,4($P-.)&>($
20
Placebo
rt-PA
31
0
10
20
30
Number of Patients
((N Engl J Med 1995:333)
40
30

31. A@d$G(*."/$*5%$?&+.*43.#$
Placebo 0.3
21
ICH Deaths
Mortality
rt-PA 3
0
17
5
10
15
20
25
Number of Patients
(N Engl J Med 1995:333)
31

32. b*/(435($QAdFF$*5%$A@d$35$."($QAQGF$2+3*4$
Percentage of t-PA Patients with Symptomatic ICH
18
16
14
12
10
8
6
4
2
0
17
2
0-5
3
6-10
5
4
11-15 16-20
>20
Baseline NIH Stroke Scale Score
(Broderick, Stroke 1997)
32

33. G3/M&/3B&5$R(/-4./$7+&>$QAQGF$2+3*4$
LOS
rt-PA
Placebo
n=312
n=312
p Value
10.88+10.04 12.41+11.10 0.02
(mean days +SD)
Disposition
0.002*
Home
151 (48%)
112(36%)
Rehab unit
91 (29%)
115 (37%)
Nursing home 22 (7%)
39 (13%)
Dead
35 (11%)
40 (13%)
Other
13 (4%)
6 (2%)
Neurology 1998;50
* compared home to all other dispositions
33

34. X^.(5%356$."($2"(+*M(-B)$!35%&'$
!
!
)*'&+$,!
!"#$
))?!
@4A?B!
CD4E?!
))?!
C4C?B!
@4E?!
!"#$
)@?!
GD?B!
CH?B!
GE?!
A?B!
C)?B!
!"#$
ID4)?!
H4H?B!
CD4J?!
%&'()*+$
§%
12'34!
%&'()*+$
F/:>>!..!
5&6$789$2!
%&'()*+$
F/:>>!
./0!
)*'&+$,-!
:;<:=;.>!
"#$%&'(!
)@4@?!
)4I?B!
CD4A?!
mRankin 0-1 for ECASS I & II, NIHSS<1 for ALANTIS at 3-months
34

35. R*5%&>3l(%$F.+(M.&035*/($2+3*4/$
Study
Time to
Treat
228 <4 hrs
MAST-I
622 <6 hrs
Mortality
SK+ASA
NA
43%
NA
22%
SK
18%
35%
Placebo
MAST-E 270 <6 hrs
Treatment ICH
ASA
ASK
N
3%
18%
SK+ASA
10%
34%
SK
6%
19%
ASA
2%
10%
Placebo
0.6%
13%
35